Trials / Completed
CompletedNCT00723736
Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)
Non-Interventional Study of the Safe Use of Aerius in Pediatric Patients With Allergic Rhinitis or Chronic Idiopathic Urticaria.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 1 Year – 5 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.
Detailed description
Pediatric patients aged 1-5 years
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desloratadine | 2.5 ml (1.25 mg) once daily |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-07-29
- Last updated
- 2022-02-09
- Results posted
- 2009-08-06
Source: ClinicalTrials.gov record NCT00723736. Inclusion in this directory is not an endorsement.